These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2753049)

  • 1. The use of the effective dose equivalent, HE, for 99mTc labelled radiopharmaceuticals.
    Huda W; Sandison GA
    Eur J Nucl Med; 1989; 15(4):174-9. PubMed ID: 2753049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis.
    Bennink RJ; Thurlings RM; van Hemert FJ; Voermans C; Dohmen SE; van Eck-Smit BL; Tak PP; Busemann-Sokole E
    J Nucl Med; 2008 Aug; 49(8):1380-5. PubMed ID: 18632808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
    Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
    J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiopharmacokinetics and radiation dose from 99mTc-HM-PAO (preliminary report).
    Deckart H; Ertl S; Blottner A; Tautz M
    Eur J Nucl Med; 1987; 13(8):429-31. PubMed ID: 3125052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of [99mTc]-d,l-HM-PAO in rat brain: an autoradiographic study.
    Hoffman TJ; Corlija M; Chaplin SB; Volkert WA; Holmes RA
    J Cereb Blood Flow Metab; 1988 Dec; 8(6):S38-43. PubMed ID: 3192640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radiation dosimetry of 99Tcm-exametazime.
    Soundy RG; Tyrrell DA; Pickett RD; Stabin M
    Nucl Med Commun; 1990 Nov; 11(11):791-9. PubMed ID: 2277692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavior of 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) in blood and brain.
    Nakamura K; Tukatani Y; Kubo A; Hashimoto S; Terayama Y; Amano T; Goto F
    Eur J Nucl Med; 1989; 15(2):100-7. PubMed ID: 2920737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
    Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
    J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc-HMPAO uptake and washout in stroke.
    Bowler JV; Wade JP
    Lancet; 1989 May; 1(8647):1140-1. PubMed ID: 2566082
    [No Abstract]   [Full Text] [Related]  

  • 10. Lacrimal gland dosimetry for the brain imaging agent technetium-99m-HMPAO.
    Villanueva-Meyer J; Thompson D; Mena I; Marcus CS
    J Nucl Med; 1990 Jul; 31(7):1237-9. PubMed ID: 2362204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal radiation dose assessment of radiopharmaceuticals prepared with cyclotron-produced
    Meléndez-Alafort L; Ferro-Flores G; De Nardo L; Bello M; Paiusco M; Negri A; Zorz A; Uzunov N; Esposito J; Rosato A
    Med Phys; 2019 Mar; 46(3):1437-1446. PubMed ID: 30661241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 99mTc-HMPAO washout in prognosis of stroke.
    Steinling M; Lassen NA
    Lancet; 1989 Mar; 1(8638):619-20. PubMed ID: 2564144
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
    Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
    J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
    Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
    Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary radiation dosimetry of a novel PET radiopharmaceutical
    Cheki M; Gali H
    Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biokinetics and dosimetric studies about 99mTc(V)-DMSA distribution.
    Correia MB; Magnata SS; Silva IM; Catanho MT; Lima FF
    Cell Mol Biol (Noisy-le-grand); 2010 May; 56(2):1-5. PubMed ID: 20525451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes.
    Brown ML; Hung JC; Vetter RJ; O'Connor MK; Chowdhury S; Forstrom LA
    Invest Radiol; 1994 Apr; 29(4):443-7. PubMed ID: 8034450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biokinetics and estimation of dose from 99mTc-labelled polyclonal human immunoglobulin (HIG).
    Saptogino A; Becker W; Wolf F
    Nuklearmedizin; 1991 Feb; 30(1):18-23. PubMed ID: 2062673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental binding and transfer of radiopharmaceuticals: technetium-99m d, 1-HMPAO.
    Owunwanne A; Omu A; Patel M; Mathew M; Ayesha A; Gopinath S
    J Nucl Med; 1998 Oct; 39(10):1810-3. PubMed ID: 9776293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99mTc-HMPAO pharmacokinetics in probands. Initial experiences with planar cerebral perfusion scintigraphy].
    Deckart H; Ertl S; Bratouss A; Tambor A
    Radiobiol Radiother (Berl); 1988; 29(2):237-42. PubMed ID: 3399665
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.